Trials / Completed
CompletedNCT01367548
Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus
A Phase II Double-Blind Randomized Parallel Group Study of Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A double-blind, randomized, parallel-group study designed to evaluate the safety and activity of IV MNTX in the treatment of Post-Operative Ileus (POI) in patients who underwent segmental colectomies via laparotomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IV Methylnaltrexone (MNTX) | |
| DRUG | Placebo |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2004-12-01
- Completion
- 2004-12-01
- First posted
- 2011-06-07
- Last updated
- 2019-11-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01367548. Inclusion in this directory is not an endorsement.